A South Korean panel of experts said Tuesday that vaccines for the novel coronavirus by U.S. pharmaceutical company Pfizer Inc. showed a more than 95 percent efficacy rate, and the use of the vaccine is not problematic for young people.

A South Korean panel of experts has said that vaccines for the novel coronavirus by AstraZeneca can be administered to elderly people amid efficacy controversies, according to the country's drug safety agency Monday.